M-Clarity™ Qualitätsstufe = MQ100
G5045-5MG
SIALG5045-5MGEA
309
EUR
InStock
SIALG5045-5MG
GW6471 ≥98% (durch HPLC), Sigma-Aldrich®
GW6471
GW6471 prevents apoptosis and cell cycle arrest at G0/G1 in renal cell carcinoma. It reduces enhanced fatty acid oxidation and oxidative phosphorylation associated with glycolysis inhibition.
GW6471 has been used:
to investigate the role of peroxisome proliferator-activated receptors (PPARs) alpha in perfluorooctanoic acid (PFOA) induced developmental cardiotoxicity
to abolish the protection of bezafibrate (BZA) against hypertrophy
to block the enhanced activity of the hepatitis B virus (HBV) core promoter